Net profit of Windlas Biotech declined 3.72% to Rs 15.00 crore in the quarter ended December 2025 as against Rs 15.58 crore during the previous quarter ended December 2024. Sales rose 19.53% to Rs 233.10 crore in the quarter ended December 2025 as against Rs 195.02 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 233.10 | 195.02 | 20 |
| OPM % | 10.46 | 12.63 | - |
| PBDT | 27.67 | 27.28 | 1 |
| PBT | 19.97 | 20.34 | -2 |
| NP | 15.00 | 15.58 | -4 |